SOPHiA Genetics (NASDAQ:SOPH) is a health tech company which focuses on data-driven medicine as the standard of care and for life sciences research. It develops a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets. It develops SOPHiA AI, an advanced technology which analyzes and detects all types of genomic variants to help clinicians better diagnose and treat their patients.